References:
1. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
2. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.
3. MiYOSMART Chameleon spectable lenses adopt a Patented Molded Laminate Photochromic Film Technologo to preserve optical performance of D.I.M.S. Technology* Reference *Patented in the United States (US9163108, US9981452, US11181666, US11427754, US11460716, US11560500)
4. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectable lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
5. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
6. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentraton atropine. Invest Ophthamlmol Vis Sci. 2016;57:2484.
7. Reaches 60% clarity after 60 seconds of fade back from the activiated state at room temperature. Initial clarity (at 23°C) is 88.4% without AR coating. Tranition for clear to 90% dark state in less than 30 seconds. Tests were conducted at room temperature (23°C).
8. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspost.org/ wspos-sunlight-exposure childrens-eyes-consensus-statement/(Last accessed 20/02/2023)
9. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225
# Children wearing MiYOSMART spectacle lens over a 6-year period had a yearly myopia progression of -0.15D and 0.10mm axial elongation on average. Lam CS, et al. Myopia control in children wearing DIMS spectacle lens: 6 years results. Invest Ophthalmol Vis Sci. 2022;63:ARVO E-Abstract 4247
